Clinical Trial Update: A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso [Phase 1, Phase 2]

View source ↗

Summary

This is a completed Phase 1/2b trial evaluating an investigational malaria vaccination strategy in infants and children in Burkina Faso.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Investigational malaria vaccine

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED